Christopher Gajda
Pfizer (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Click Chemistry and Applications, HIV Research and Treatment, Synthetic Organic Chemistry Methods, Asymmetric Synthesis and Catalysis
Most-Cited Works
- → Kinetics of denitrification by Pseudomonas fluorescens: Oxygen effects(1994)70 cited
- → Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors: The Profound Effect of Polarity on Antiviral Activity(1997)62 cited
- → 4-Hydroxy-5,6-dihydropyrones as Inhibitors of HIV Protease: The Effect of Heterocyclic Substituents at C-6 on Antiviral Potency and Pharmacokinetic Parameters(2001)59 cited
- → 5,6-Dihydropyran-2-ones Possessing Various Sulfonyl Functionalities: Potent Nonpeptidic Inhibitors of HIV Protease(2000)50 cited
- → 4-Hydroxy-5,6-dihydropyrones. 2. Potent Non-Peptide Inhibitors of HIV Protease(1997)48 cited
- → Studies in the asymmetric ring opening of an oxabicyclic compound. Catalytic asymmetric induction using (–)-sparteine(1993)37 cited
- → Discovery and optimization of nonpeptide HIV-1 protease inhibitors(1996)29 cited
- → Stereospecific Synthesis of Vinylsilanes via Trimethylsilyl-Substituted Allyliron Cations(1992)19 cited
- → Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor(1999)17 cited
- → An efficient synthesis of highly substituted 1,3-cycloheptadienes from oxabicyclo[3.2.1]octenes. Solvent effects in the ring opening reaction(1993)11 cited